tk88 bet

COVID-19 vaccines approved for use in Vietnam go through three clinical trial phases: ministry

All types of COVID-19 vaccine approved by Vietnam for emergency use have gone through three stages of clinical trials, the Health Ministry has affirmed.
COVID-19 vaccines approved for use in Vietnam go through three clinical trial phases: ministry ảnh 1COVID-19 vaccine (Photo: VNA)
Hanoi (VNA) - All types of COVID-19 vaccine approved by Vietnam for emergency use have gone through three stages of clinical trials, the HealthMinistry has affirmed.

As of June 23, Vietnam has conditionally approved fourvaccines against COVID-19, namely Comirnaty of Pfizer, A2D1222 of AstraZeneca,Sputnik-V of Gamalaya, and Vero-Cell of Sinopharm to serve urgent needs of pandemicprevention and control, the ministry said, adding that Moderna vaccine is alsoin the process of being approved.

Following international practice, all vaccines, before beingput into emergency use in Vietnam, must ensure three factors of safety,immunogenicity and most importantly, protection effectiveness.

All of the above-mentioned vaccines had to go through threephases of clinical trials, of which the third phase involved from 20,000 to 50,000participants.

Specifically, the third phase of AstraZeneca's vaccine wascarried out in 11 countries with 49,626 participants, Vero-Cell vaccine in sixcountries with over 45,000 participants, Sputnik-V in five countries with21,977 participants, Pfizer's vaccine in six countries with 43,418participants, and Moderna vaccine in four countries with 30,420 participants,according to the ministry.

In the context of COVID-19 breaking out worldwide, theurgent authorisation of a vaccine against the disease is necessary. However, this doesnot mean skipping the mandatory clinical trial stages, the ministry added./.
VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

🍷 Forum spotlights AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
A banner on the side of a car urges people to quit smoking for their own health and that of their loved ones (Photo: VNA)

💫 Sharp tobacco tax hike urged to safeguard youths, community health

A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
On the morning of May 26, 2025, following bilateral talks at the Presidential Palace, President Luong Cuong (first, right) and French President Emmanuel Macron (first, left) witness the exchange of cooperation documents between leaders of ministries, agencies, and enterprises from both countries. In the photo: Ngo Chi Dung, General Director and Chairman of the Board of Viet Nam Vaccine Company (VNVC) (second, right), and Zainab Sadat Qayyum, President of Sanofi Southeast Asia – India, exchange the cooperation agreement on the transfer of Sanofi’s vaccine production technology to VNVC’s vaccine and biologicals plant. (Photo: VNVC)

ꦏ Vietnam, France collaborate in vaccine production technology transfer

Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|